SiT for maintenance/relief vs higher‐dose ICS/LABA + SABA
Patients with severe exacerbations (requiring hospitalisation or ER visit) · Studies recruited adults and adolescents aged 12 and older with chronic asthma
SiT for maintenance/relief leads to lower patients with severe exacerbations (requiring hospitalisation or ER… compared with higher‐dose ICS/LABA + SABA (high certainty).
1 finding from 1 review
- Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for… 2013 · Cochrane Headline outcomes onlyOR 0.72 [0.57, 0.9]7768 participantsHigh